InnoTherapy Inc Asset Resilience Ratio
InnoTherapy Inc asset resilience ratio. InnoTherapy Inc (246960) has an Asset Resilience Ratio of 4.79% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See InnoTherapy Inc (246960) liquidity interval to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of InnoTherapy Inc (2015–2024)
Asset resilience ratio of InnoTherapy Inc from 2015 to 2024. This chart shows how InnoTherapy Inc's Asset Resilience Ratio has changed over time. Read 246960 total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down InnoTherapy Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see 246960 asset base.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩3.61 Billion | 4.79% |
| Total Liquid Assets | ₩3.61 Billion | 4.79% |
Asset Resilience Insights
- Limited Liquidity: InnoTherapy Inc maintains only 4.79% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
InnoTherapy Inc Industry Peers by Asset Resilience Ratio
Compare InnoTherapy Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
HOB Biotech Group Corp Ltd
SHG:688656 |
Medical Devices | 2.62% |
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
|
Applied BioCode
TW:6598 |
Medical Devices | 9.75% |
|
Oncosil Medical Ltd
AU:OSL |
Medical Devices | 0.00% |
|
Cleo Diagnostics Ltd
AU:COV |
Medical Devices | 94.64% |
|
Radiant Innovation
TWO:3373 |
Medical Devices | 0.82% |
|
Impedimed Ltd
AU:IPD |
Medical Devices | 46.15% |
|
Memphasys Ltd
AU:MEM |
Medical Devices | 0.00% |
InnoTherapy Inc Asset Resilience Ratio by Year (2015–2024)
InnoTherapy Inc asset resilience ratio by year from 2015 to 2024. The table below shows the annual Asset Resilience Ratio data for InnoTherapy Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 4.63% | ₩1.11 Billion ≈ $754.66K |
₩24.06 Billion ≈ $16.30 Million |
-24.49pp |
| 2023-12-31 | 29.12% | ₩8.78 Billion ≈ $5.95 Million |
₩30.16 Billion ≈ $20.44 Million |
+16.48pp |
| 2022-12-31 | 12.64% | ₩3.89 Billion ≈ $2.64 Million |
₩30.81 Billion ≈ $20.88 Million |
-20.05pp |
| 2021-12-31 | 32.68% | ₩10.42 Billion ≈ $7.06 Million |
₩31.88 Billion ≈ $21.61 Million |
+5.95pp |
| 2020-12-31 | 26.73% | ₩4.64 Billion ≈ $3.14 Million |
₩17.35 Billion ≈ $11.76 Million |
-35.67pp |
| 2019-12-31 | 62.40% | ₩10.75 Billion ≈ $7.29 Million |
₩17.23 Billion ≈ $11.68 Million |
+32.50pp |
| 2018-12-31 | 29.90% | ₩3.34 Billion ≈ $2.26 Million |
₩11.18 Billion ≈ $7.57 Million |
+24.62pp |
| 2017-12-31 | 5.28% | ₩222.05 Million ≈ $150.48K |
₩4.20 Billion ≈ $2.85 Million |
-24.25pp |
| 2016-12-31 | 29.53% | ₩2.08 Billion ≈ $1.41 Million |
₩7.03 Billion ≈ $4.77 Million |
+3.29pp |
| 2015-12-31 | 26.24% | ₩2.13 Billion ≈ $1.44 Million |
₩8.11 Billion ≈ $5.50 Million |
-- |
About InnoTherapy Inc
SCL Science Inc. produces medical hemostatic agents using biomimetic technology. Its products include BiMM (Bio-inspired Medical Materials) that reacts immediately with blood; Endoseal, which is used for specialized indication of gastrointestinal bleeding; InnoSeal, a hemostatic agent that is used in various surgical fields, such as cardiology, radiology, and neurosurgery; Jelly Seal, a hemostasi… Read more